Methods of treating vascular diseases characterized by nitric oxide insufficiency
CA 2678256 A1 · Owner: Loscalzo, Joseph · Inventors: Loscalzo, Joseph; Vita, Joseph A.; Worcel, Manuel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods of treating or preventing vascular diseases , caused by nitric oxide (NO) insufficiency. The methods encompass administering a composition , comprising an antioxidant a compound to treat cardiovascular diseases a , nitrosated compound, a compound that donates transfers or relases NO, or is a NO synthase substrate, or endogenously , stimulates NO synthesis or stimulates levels of endothelium derived relaxing factor. In the said , composition, a hydralazine compound may be an antioxidant isosorbide mono-or , dinitrate may , be the compound to donate transfer, release, or stimulate endogenous NO synthesis. The , isorsorbide may also elevate …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 2, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 2, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 2, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.